ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
May 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
India’s PFBR attains criticality at last
Prime Minister Narendra Modi proclaimed it “a proud moment for India” when on April 6 the 500-MWe, sodium-cooled Prototype Fast Breeder Reactor (PFBR) achieved initial criticality. This milestone, which comes some 22 years after the continually delayed PFBR project began, marks India’s entrance into the second stage of its three-stage nuclear program, which has the ultimate goal of supporting the country’s nuclear power program with its significant thorium reserves.
Joetta Goda, Caiser Bravo, Theresa Cutler, Travis Grove, David Hayes, Jesson Hutchinson, George McKenzie, Alexander McSpaden, William Myers, Rene Sanchez, Jessie Walker
Nuclear Science and Engineering | Volume 195 | Number 1 | November 2021 | Pages S55-S79
Technical Paper | doi.org/10.1080/00295639.2021.1947103
Articles are hosted by Taylor and Francis Online.
The work presented in this paper focuses on the first 10 years (2011–2020) of Godiva IV operations at the National Criticality Experiments Research Center (NCERC). Godiva IV is a fast burst critical assembly constructed of approximately 65 kg of highly enriched uranium fuel alloyed with 1.5% molybdenum for strength. Godiva is one of the last such critical assemblies in the United States and can be used for studies of super-prompt-critical behavior as well as irradiations and demonstrations. An overview of the startup of Godiva IV at NCERC is given followed by a summary of the experiments performed utilizing Godiva IV over the first 10 years of operation at NCERC.